JAMAs Post JAMA 222,534 followers Report this post Use of GLP-1 agonists for weight loss, compared with use of bupropion-naltrexone, was associated with an increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease
These are not abstract numbers
Key Benefits: Promotes natural GLP-1 hormone response
Understanding Semaglutide Semaglutide mimics the action of glucagon-like peptide-1 (GLP-1), enhancing insulin secretion, reducing glucagon levels, slowing gastric emptying, and decreasing appetite
Hanefeld M, et al
The broader question you should be asking yourself is this: Are you ready to move beyond the outdated eat less and move more prescription and start leveraging the most advanced metabolic science available